嗜酸性粒细胞增多综合征合并外周动脉栓塞患者的临床特点分析

doi:10.16352/j.issn.1001-6325.2024.08.1157

基础医学与临床 ›› 2024, Vol. 44 ›› Issue (8): 1157-1161.doi: 10.16352/j.issn.1001-6325.2024.08.1157

嗜酸性粒细胞增多综合征合并外周动脉栓塞患者的临床特点分析

韩迎东^1#, 王嵩^1,2#, 张昀^1*, 曾学军¹

1.中国医学科学院北京协和医学院北京协和医院全科医学科(普通内科),北京 100730;
2.宿松县中医院内科,安徽安庆 246500

收稿日期:2023-12-13 修回日期:2024-01-23 出版日期:2024-08-05 发布日期:2024-07-24
通讯作者: ^*zhangyun10806@pumch.cn
作者简介:^#对本文有相同贡献
基金资助:
北京市临床重点专科项目(2023);北京协和医学院临床医学专业全科医学人才培养项目(201920200106)

Analysis of clinical features of hypereosinophilic syndrome complicated with peripheral arterial embolism

HAN Yingdong^1#, WANG Song^1,2#, ZHANG Yun^1*, ZENG Xuejun¹

1. Department of General Internal Medicine, Peking Union Medical College Hospital, CAMS & PUMC, Beijing 100730;
2. Department of Internal Medicine, Susong County Hospital of Traditional Chinese Medicine, Anqing 246500, China

Received:2023-12-13 Revised:2024-01-23 Online:2024-08-05 Published:2024-07-24
Contact: ^*zhangyun10806@pumch.cn

摘要/Abstract

摘要： 目的分析伴外周动脉栓塞的嗜酸性粒细胞增多综合征(HES)患者的临床特点及治疗效果,以提高临床医生的对该疾病的认识。方法从2012年4月至2021年10月北京协和医院的住院患者中进行入组挑选,通过电子病例系统收集了176例外周动脉栓塞的患者,根据纳入排除标准,共纳入13例HES伴外周动脉栓塞的患者,以上患者均通过影像学检查证实存在外周动脉栓塞。经过年龄及性别匹配,按照1∶3的比例筛选出同期住院的不伴外周动脉栓塞的39例HES患者作为对照组。比较两组患者在临床资料、治疗方案及治疗反应方面的差异。结果病例组13例患者有11例男性。主要栓塞部位为下肢腘动脉、足背动脉及上肢桡动脉、尺动脉。伴外周动脉栓塞组的患者周围神经受累情况显著高于不伴外周动脉栓塞组(P＜0.05);胃肠道受累比例(P＜0.05)及嗜酸性粒细胞水平(P＜0.05)显著低于不伴外周动脉栓塞组。伴外周动脉栓塞组中分别有92.3%、61.5%和76.9%的患者接受抗凝、抗血小板和免疫抑制剂治疗,均显著高于未合并外周动脉栓塞组患者(P＜0.05)。根据治疗前后嗜酸性粒细胞水平变化,住院期间病例组和对照组患者分别有84.6%和56.5%的患者完全缓解,部分缓解率分别为15.4%和25.6%。结论伴外周动脉栓塞的HES患者中,周围神经和皮肤为常见受累脏器,血管栓塞以四肢动脉栓塞为主,经过激素、免疫抑制剂及抗凝和/或抗血小板治疗,该组患者预后良好。

关键词: 嗜酸性粒细胞综合征, 动脉栓塞, 周围神经受累, 抗凝治疗

Abstract: Objective To improve the understanding of hypereosinophilic syndrome (HES) complicated with peripheral arterial embolism through analyzing the clinical features and therapeutic effect. Methods Among 176 inpatients with peripheral arterial embolism in Peking Union Medical College Hospital from April 2012 to October 2021, 13 patients complicated with HES were involved according to the inclusion and exclusion criteria. All patients were diagnosed with peripheral arterial embolism by imaging examination. After gender and age matching, 39 HES patients who were hospitalized in the same period but without peripheral arterial embolism were selected as the control with the ratio of 1∶3. Clinical features, therapy response and prognosis were compared between the two groups. Results Eleven of the 13 patients were male. The main involved arteries included popliteal artery, dorsalis pedis artery, ulnar artery and radial artery. The proportion of peripheral nerve involvement in case group was significantly higher than in the control group (P＜0.05); and the proportion of gastrointestinal involvement(P＜0.05) and eosinophil level (P＜0.05) were significantly lower than that of control group. There were 92.3%, 61.5% and 76.9% of the patients in case group received anticoagulant therapy, antiplatelet therapy and immunosuppressive therapy respectively, the percentages were significantly higher than that in control group(P＜0.01). According to eosinophil counts before and after therapy, 84.6% and 56.5% of the patients in the case and control groups achieved complete remission and the partial remission rates were 15.4% and 25.6% respectively. Conclusions Patients with hypereosinophilia syndrome and peripheral arterial embolism commonly experience involvement of the peripheral nerves and skin. Vascular embolism is mainly caused by arterial embolization of the extremities. After treatment with hormones, immunosuppressants, anticoagulants and/or antiplatelet therapy, this group of patients has a good prognosis.

Key words: hypereosinophilic syndrome, arterial embolism, peripheral nerve system, anticoagulant therapy

中图分类号:

韩迎东, 王嵩, 张昀, 曾学军. 嗜酸性粒细胞增多综合征合并外周动脉栓塞患者的临床特点分析[J]. 基础医学与临床, 2024, 44(8): 1157-1161.

HAN Yingdong, WANG Song, ZHANG Yun, ZENG Xuejun. Analysis of clinical features of hypereosinophilic syndrome complicated with peripheral arterial embolism[J]. Basic & Clinical Medicine, 2024, 44(8): 1157-1161.

参考文献

[1] Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease(TASC II)[J]. Eur J Vasc Endovasc Surg, 2007, 33 Suppl 1:S1-75.
[2] Lowe GD. Venous and arterial thrombosis: epidemiology and risk factors at various ages[J]. Maturitas, 2004, 47:259-263.
[3] Curtis C, Ogbogu P. Hypereosinophilic syndrome[J]. Clin Rev Allergy Immunol, 2016, 50:240-251.
[4] Requena G, Logie J, Gibbons DC, et al. The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom[J]. Immun Inflamm Dis, 2021, 9:1447-1451.
[5] 韩迎东,王嵩,韩欣欣,等. 25例伴外周动脉闭塞的嗜酸性粒细胞增多症患者临床特点分析[J]. 基础医学与临床,2023,43:785-789.
[6] Takeuchi H, Kawamura K, Kawasaki T, et al. Distinct features of hypereosinophilic syndrome with neuropathy from eosinophilic granulomatosis with polyangiitis[J]. Front Neurol, 2022, 13:1057767. doi: 10.3389/fneur.2022.
[7] Ackerman SJ, Bochner BS. Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders[J]. Immunol Allergy Clin North Am, 2007, 27:357-375.
[8] Moosbauer C, Morgenstern E, Cuvelier SL, et al. Eosinophils are a major intravascular location for tissue factor storage and exposure[J]. Blood, 2007, 109:995-1002.
[9] Kanno H, Ouchi N, Sato M, et al. Hypereosinophilia with systemic thrombophlebitis[J]. Human pathology, 2005, 36:585-589.
[10] 宋小军,刘昌伟. 特发性嗜酸性粒细胞增多症累及周围血管治疗体会[J]. 临床外科杂志, 2008, 16:778-779.
[11] 胡海地,常青,陈喆,等. 急性肢体动脉栓塞患者的外科诊治及预后分析[J]. 中华医学杂志, 2011, 91:2923-2926.
[12] Klion A. Hypereosinophilic syndrome: current approach to diagnosis and treatment[J]. Annu Rev Med, 2009, 60:293-306.

[1]	宋丽丽, 管玉洁, 马平, 李宁. 急性髓系白血病患儿柔红霉素耐药与PD-L1蛋白表达相关[J]. 基础医学与临床, 2024, 44(6): 833-839.
[2]	傅晨, 李平. 重型再生障碍性贫血治疗的研究进展[J]. 基础医学与临床, 2024, 44(5): 719-723.
[3]	赵卫红, 黄彬涛, 刘瑞, 向彩霞. 评价具有CD20^-或CD20⁺特征的t(11;14)骨髓瘤患者临床疗效差异性[J]. 基础医学与临床, 2023, 43(9): 1423-1427.
[4]	韩迎东, 王嵩, 韩欣欣, 尹月, 王玉, 张昀, 曾学军. 25例伴外周动脉闭塞的嗜酸性粒细胞增多症患者临床特点分析[J]. 基础医学与临床, 2023, 43(5): 785-789.
[5]	向彩霞, 黄彬涛, 郝建. 抗凋亡抑制剂维奈克拉在治疗髓系白血病的研究进展[J]. 基础医学与临床, 2023, 43(5): 833-836.
[6]	邓玲, 龙岚, 杨阳, 靳婵婵, 李苏云, 丰娜, 贺静. HBG基因启动子区rs368698783、rs7482144位点多态性与HbF表达相关[J]. 基础医学与临床, 2023, 43(2): 211-218.
[7]	刘婷, 曹欣欣. Rosai-Dorfman病的诊治进展[J]. 基础医学与临床, 2022, 42(11): 1785-1790.
[8]	张若曦, 韩冰. 免疫检查点抑制剂治疗骨髓增生异常综合征的研究进展[J]. 基础医学与临床, 2021, 41(8): 1210-1215.
[9]	高小燕, 刘述川. 端粒缩短与骨髓衰竭性疾病的研究进展[J]. 基础医学与临床, 2021, 41(1): 116-119.
[10]	刘宁, 张伟华. 糖尿病合并高血压加重血管病变的研究进展[J]. 基础医学与临床, 2020, 40(7): 990-994.
[11]	陈苗, 吴亚妹, 周道斌, 段明辉, 庄俊玲, 韩冰, 吴晓雄. 强化免疫抑制治疗和单倍体移植治疗年轻重型再生障碍性贫血的比较[J]. 基础医学与临床, 2020, 40(6): 759-764.
[12]	张若曦, 李红敏, 伍洁, 韩冰. 检测血液参数在常见小细胞性贫血患者中诊断鉴别的意义[J]. 基础医学与临床, 2020, 40(1): 105-109.
[13]	李思倩朱子璇文煜冰庄俊玲陈丽萌李雪梅李明喜. 多发性骨髓瘤管型肾病和肾淀粉样变性的临床特征及预后分析[J]. 基础医学与临床, 2019, 39(10): 1483-1487.
[14]	陈苗庄俊玲. 低剂量利妥昔单抗治疗温抗体型自身免疫性溶血性贫血的系统评价[J]. 基础医学与临床, 2017, 37(10): 1444-1448.
[15]	李丽君刘蓓徐茜刘欢. 急性髓系白血病患者化疗后微小残留病与多药耐药基因表达相关[J]. 基础医学与临床, 2017, 37(1): 62-66.

嗜酸性粒细胞增多综合征合并外周动脉栓塞患者的临床特点分析

Analysis of clinical features of hypereosinophilic syndrome complicated with peripheral arterial embolism

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价